Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NNNB: Simplification to Maraviroc-Raltegravir Dual Therapy in HIV-1
NCT01291459Phase 2Unknown
- Sponsor
- Association Pour la Recherche en Infectiologie
- Start
- Sep 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of maraviroc, raltegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Association Pour la Recherche en Infectiologie. Status: unknown.
02
Drugs
maravirocraltegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01291459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01291459.